← Leaderboards
Christopher Joachim Lengner
Whitehead Institute For Biomedical Res
$8,750,139
Attributed
$10,398,949
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,398,949 · 6
By mechanism
R01$9,477,883 · 3
R21$442,750 · 1
R56$333,116 · 1
F32$145,200 · 1
Top collaborators
- Frederick Bradley Johnson7 shared
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- Omer Yilmaz$16,106,393
- David M Sabatini$25,995,600
- Peter Reddien$6,564,141
- Thijn Brummelkamp$1,984,590
- Maria M. Mihaylova$3,269,473
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIntestinesIn VivoStem CellsBaseResponsePathway InteractionsMouse ModelIntestinal EpitheliumAllelesEpithelialCell TypeMolecularGeneticTherapeutic InterventionRna-Binding ProteinsAutomobile DrivingFamilyStem Cell PopulationSignal TransductionMutationExhibitsGenesHomeostasis
Grant awards (31)
Aging and Telomere Dysfunction in the Intestinal Stem Cell Niche$333,116
R56 · FY2025 · AG · contact PI
The basis for and function of enteroendocrine lineage plasticity in the intestinal DNA damage response$425,279
R01 · FY2023 · DK · contact PI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA$629,822
R01 · FY2022 · HL
The basis for and function of enteroendocrine lineage plasticity in the intestinal DNA damage response$432,361
R01 · FY2022 · DK · contact PI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA$630,241
R01 · FY2021 · HL
The basis for and function of enteroendocrine lineage plasticity in the intestinal DNA damage response$440,575
R01 · FY2021 · DK · contact PI
Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation$382,375
R01 · FY2021 · CA · contact PI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA$630,648
R01 · FY2020 · HL
The basis for and function of enteroendocrine lineage plasticity in the intestinal DNA damage response$451,596
R01 · FY2020 · DK · contact PI
Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation$382,375
R01 · FY2020 · CA · contact PI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA$631,043
R01 · FY2019 · HL
Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation$370,903
R01 · FY2019 · CA · contact PI
Control of intestinal regeneration by an Msi-mTORC1 signaling axis$362,250
R01 · FY2019 · DK · contact PI
Control of intestinal regeneration by an Msi-mTORC1 signaling axis$72,722
R01 · FY2019 · DK · contact PI
Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation$382,375
R01 · FY2018 · CA · contact PI
Control of intestinal regeneration by an Msi-mTORC1 signaling axis$362,250
R01 · FY2018 · DK · contact PI
Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation$382,375
R01 · FY2017 · CA · contact PI
Control of intestinal regeneration by an Msi-mTORC1 signaling axis$362,250
R01 · FY2017 · DK · contact PI
A novel and tractable model to address telomere dysfunction in a human tissue$201,250
R21 · FY2017 · AG
Control of intestinal regeneration by an Msi-mTORC1 signaling axis$362,063
R01 · FY2016 · DK · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$332,000
R01 · FY2016 · CA · contact PI
A novel and tractable model to address telomere dysfunction in a human tissue$241,500
R21 · FY2016 · AG
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$383,420
R01 · FY2015 · CA · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$51,420
R01 · FY2015 · CA · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$322,040
R01 · FY2014 · CA · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$51,420
R01 · FY2014 · CA · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$312,080
R01 · FY2013 · CA · contact PI
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis$332,000
R01 · FY2012 · CA · contact PI
Control of Somatic Stem Cell Proliferation by Oct4$50,428
F32 · FY2008 · CA · contact PI
Control of Somatic Stem Cell Proliferation by Oct4$48,796
F32 · FY2007 · CA · contact PI
Control of Somatic Stem Cell Proliferation by Oct4$45,976
F32 · FY2006 · CA · contact PI